Your browser doesn't support javascript.
loading
A functional variant in TP63 at 3q28 associated with bladder cancer risk by creating an miR-140-5p binding site.
Wang, Meilin; Du, Mulong; Ma, Lan; Chu, Haiyan; Lv, Qiang; Ye, Dingwei; Guo, Jianming; Gu, Chengyuan; Xia, Guowei; Zhu, Yao; Ding, Qiang; Yuan, Lin; Fu, Guangbo; Tong, Na; Qin, Chao; Yin, Changjun; Xu, Jianfeng; Zhang, Zhengdong.
Afiliação
  • Wang M; Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China.
  • Du M; Department of Genetic Toxicology, The Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Ma L; Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China.
  • Chu H; Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China.
  • Lv Q; Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China.
  • Ye D; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Guo J; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China.
  • Gu C; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Xia G; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China.
  • Zhu Y; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China.
  • Ding Q; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China.
  • Yuan L; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China.
  • Fu G; Department of Urology, Jiangsu Province Hospital of TCM, Nanjing, China.
  • Tong N; Department of Urology, The Huai-An First Affiliated Hospital, Nanjing Medical University, Nanjing, China.
  • Qin C; Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China.
  • Yin C; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Xu J; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Zhang Z; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Int J Cancer ; 139(1): 65-74, 2016 Jul 01.
Article em En | MEDLINE | ID: mdl-26695686
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Neoplasias da Bexiga Urinária / Predisposição Genética para Doença / Proteínas Supressoras de Tumor / MicroRNAs Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Neoplasias da Bexiga Urinária / Predisposição Genética para Doença / Proteínas Supressoras de Tumor / MicroRNAs Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article